Want to see AU:EVE full AI Analyst Report?
EVE Stock Chart & Stats
AU$0.02
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.02
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.04
Previous CloseN/A
Volume9.81K
Average Volume (3M)395.23K
Market Cap
AU$6.34M
Enterprise ValueAU$4.86
Total Cash (Recent Filing)AU$1.24M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta0.22
Next Earnings
Mar 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding352,326,600
10 Day Avg. Volume340,058
30 Day Avg. Volume395,229
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)1.40
Price to Sales (P/S)4.80
P/FCF Ratio-3.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Very Low LeverageThe effectively debt-free 2026 position reduces refinancing exposure and interest costs, giving EVE greater financial flexibility while it restructures. This conservative capital structure provides resilience against operating volatility and preserves more options for future funding and investment.
Positive Equity BufferPositive and improving equity gives EVE a balance-sheet buffer against continuing losses and supports its ability to manage the restructuring period. Although it does not solve the profitability issue, this capital base is a durable support relative to a more highly leveraged competitor.
Losses Have NarrowedThe reduction in losses from the weakest prior years indicates some improvement in financial performance, even though EVE remains unprofitable. If maintained, this progress could lower the distance to break-even and improve the company's ability to stabilize its branded health-products business.
Bears Say
Persistent UnprofitabilityPersistent operating and net losses show that sales are not covering the company's cost base, while negative gross profit in 2026 signals particularly severe pressure on the underlying economics. This weakens reinvestment capacity and makes a durable return to profitability uncertain.
Declining RevenueSeveral years of falling sales indicate that EVE is shrinking rather than scaling toward break-even. Continued revenue contraction can reduce operating leverage, weaken brand and distribution momentum, and make it harder for fixed costs to be covered without further restructuring.
Ongoing Cash BurnRepeated negative operating and free cash flow means the business is consuming cash rather than funding itself internally. Even with minimal debt, continued cash burn increases reliance on external funding or existing balance-sheet resources and limits strategic flexibility over the coming periods.
EVE Health Group Limited News
EVE FAQ
What was EVE Health Group Limited’s price range in the past 12 months?
EVE Health Group Limited lowest share price was AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is EVE Health Group Limited’s market cap?
EVE Health Group Limited’s market cap is AU$6.34M.
When is EVE Health Group Limited’s upcoming earnings report date?
EVE Health Group Limited’s upcoming earnings report date is Mar 01, 2027 which is in 162 days.
How were EVE Health Group Limited’s earnings last quarter?
EVE Health Group Limited released its earnings results on Aug 31, 2026. The company reported -AU$0.003 earnings per share for the quarter.
Is EVE Health Group Limited overvalued?
According to Wall Street analysts EVE Health Group Limited’s price is currently Overvalued.
Does EVE Health Group Limited pay dividends?
EVE Health Group Limited does not currently pay dividends.
What is EVE Health Group Limited’s EPS estimate?
EVE Health Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EVE Health Group Limited have?
EVE Health Group Limited has 352,326,600 shares outstanding.
What happened to EVE Health Group Limited’s price movement after its last earnings report?
EVE Health Group Limited reported an EPS of -AU$0.003 in its last earnings report. Following the earnings report the stock price went down -6.667%.
Which hedge fund is a major shareholder of EVE Health Group Limited?
Currently, no hedge funds are holding shares in AU:EVE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
EVE Health Group Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.93%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
3.68%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
EVE Health Group Limited
Based in Subiaco, Australia, Eve Health Group Limited, originally incorporated in 2003 as EVE Investments Limited, is an international provider of health, wellness, and nutritional products. The company operates across Australia, New Zealand, the Asia Pacific region, and North America. Its activities include the production of organic tea tree oils, the distribution of botanical oils, and the supply of a wide array of other oils such as essential oils, hydrosols, extracts, carrier oils, and seed oils. Furthermore, Eve Health Group offers organic raw honey and raw honey probiotic concentrates, alongside contract manufacturing services. A key area of its focus is developing medical nutrition solutions for chronic and lifestyle ailments, exemplified by Gluco Smooth, a product designed to help manage type 2 diabetes by moderating post-meal blood sugar levels, as well as providing various dietary intervention programs.
Technical Analysis
Australian Dairy Nutritionals Group
―
―
Nuchev Pty Ltd
―
Holista Colltech Limited
―
Nutritional Growth Solutions Ltd.
―